Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed3
Recruiting1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03861871Phase 2Completed
Fenfluramine in CDKL5 Deficiency Disorder (CDD)
CDD
PrincipalinvestigatorStart date: 2019-10-29
NCT03109197Recruiting
Sudden Unexplained Death in Childhood (SUDC) Registry
Sudden Unexplained Death in ChildhoodSudden Unexplained Death Syndrome
PrincipalinvestigatorStart date: 2014-10-01
NCT02451696Phase 2Completed
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
EpilepsyFocal Cortical DysplasiaTuberous Sclerosis Complex
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03861871Phase 2PrincipalInvestigator

Fenfluramine in CDKL5 Deficiency Disorder (CDD)

CDD
Completed
NCT03109197PrincipalInvestigator

Sudden Unexplained Death in Childhood (SUDC) Registry

Sudden Unexplained Death in ChildhoodSudden Unexplained Death Syndrome
Recruiting
NCT02451696Phase 2PrincipalInvestigator

A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD

EpilepsyFocal Cortical DysplasiaTuberous Sclerosis Complex
Completed
NCT02758626Phase 2PrincipalInvestigator

Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome

Epilepsy
Completed

All 4 trials loaded